PALO ALTO, Calif.–(BUSINESS WIRE)–Frazier Life Sciences Acquisition Corp. II (the “Company”), a special purpose acquisition company, announced today that it priced its initial public offering of 7,500,000 Class A ordinary shares at a price of $10.00 per share. The Class A ordinary shares will be listed on The Nasdaq Capital Market and trade under the ticker symbol “FLSC” beginning on October 14, 2026. The offering is expected to close on October 15, 2026, subject to customary closing conditio